Invention Grant
- Patent Title: Nano-emulsion of CBFß-RUNX1 inhibitor for ocular drug delivery
-
Application No.: US16763932Application Date: 2018-11-14
-
Publication No.: US11583497B2Publication Date: 2023-02-21
- Inventor: Leo A. Kim , Joseph F. Arboleda-Velasquez
- Applicant: The Schepens Eye Research Institute, Inc.
- Applicant Address: US MA Boston
- Assignee: The Schepens Eye Research Institute, Inc.
- Current Assignee: The Schepens Eye Research Institute, Inc.
- Current Assignee Address: US MA Boston
- Agency: Fish & Richardson P.C.
- International Application: PCT/US2018/061156 WO 20181114
- International Announcement: WO2019/099595 WO 20190523
- Main IPC: A61K9/00
- IPC: A61K9/00 ; A61K9/107 ; A61K31/5513 ; A61K47/10 ; A61K47/14 ; A61K47/24 ; A61K9/19

Abstract:
The invention provides ocular formulations and features a nano-emulsion composition, e.g., a nano-emulsion comprising a CBFβ-RUNX1 inhibitor. The composition comprises a particle with a length of less than 200 nanometers in at least one dimension.
Public/Granted literature
- US20200375899A1 NANO-EMULSION OF CBFß-RUNX1 INHIBITOR FOR OCULAR DRUG DELIVERY Public/Granted day:2020-12-03
Information query